Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
445
+71
+19% +$24.3K 0.02% 182
2026
Q1
$132K Buy
374
+25
+7% +$8.91K 0.02% 184
2025
Q4
$114K Sell
349
-3
-0.9% -$952 0.02% 219
2025
Q3
$99.3K Buy
+352
New +$102K 0.01% 232
2023
Q1
Sell
-797
Closed -$209K 125
2022
Q4
$209K Buy
+797
New +$214K 0.07% 128

Other funds holding AMGN

Financial Consulate's AMGN Position: Q2 2026 in Review

Financial Consulate increased its Amgen (AMGN) stake by 19% in Q2 2026, buying an estimated $24.3K and bringing the position to 445 shares worth $161K. The position accounts for 0.02% of the portfolio, ranked #182.

Financial Consulate first reported a position in AMGN in Q4 2022 and has held it in 5 quarters since. The position peaked at $209K in Q4 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Financial Consulate held 445 shares of Amgen worth $161K as of Q2 2026.
  • Financial Consulate bought 71 Amgen shares in Q2 2026, an estimated $24.3K.
  • Amgen made up 0.02% of Financial Consulate's portfolio in Q2 2026, its #182 holding.
  • Financial Consulate first reported a position in Amgen in Q4 2022 and has held it in 5 quarters since.
  • Financial Consulate's Amgen position peaked at $209K in Q4 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.